Pharmascience has since launched its first products in Bulgaria and Albania, providing patients with innovative Oncology and CNS formulations as well as quality generic products.
Mainly focusing on high quality Oncology generics, Pharmascience’s expansion plan for the next year in CEE include the launch of 10 major products in 8 countries, with more to come in the years to follow.
Pharmascience is increasingly focused on establishing a solid presence in the region. The strategic market expansion in CEE is driven by Pharmascience International’s local team in Sofia, Bulgaria.
Founded in 1983, Pharmascience Inc. is one of the largest pharmaceutical manufacturers in Canada with over 1,500 employees, and an international presence spanning 60 countries. Pharmascience’s global presence and agile business development model provides patients and healthcare communities around the world with the same quality medicines as are dispensed in Canada. Its R&D team has the extensive expertise necessary for the development of complex injectable and solid oral generic drugs.
Pharmascience has been distributing high-quality, FDA certified generic products in the US since 2017 from our Candiac site. Since its inception in 1983, Pharmascience has invested over $500M in research and development and ranks amongst the top generic manufacturers in Canada, offering over 300 product families in more than 20 dosage forms. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.
For media inquiries